These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16880014)

  • 1. Tace treatment outcome: (almost) everything is predictable.
    Giannelli G; Vella FS; Antonaci S; Foti C; Filotico R
    Dig Liver Dis; 2006 Dec; 38(12):940-1. PubMed ID: 16880014
    [No Abstract]   [Full Text] [Related]  

  • 2. [A small-sized hepatocellular carcinoma].
    Barbare JC
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis C virus-related hepatocellular carcinoma].
    Sumi H; Yokosuka O
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():440-5. PubMed ID: 11761989
    [No Abstract]   [Full Text] [Related]  

  • 4. [An unusual complication of hepatocellular carcinoma: the pleuro-biliary fistula].
    Tirotta D; Durante V
    Recenti Prog Med; 2009 Feb; 100(2):84-6. PubMed ID: 19350800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis.
    Vautravers C; Rat P; Cercueil JP; Moreau T; Horiot JC; Chauffert B
    Eur J Intern Med; 2008 Dec; 19(8):e86-7. PubMed ID: 19046712
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
    La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
    Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of hepatocellular carcinoma. New developments].
    Kuiken SD; van Delden OM; Richel DJ; Jansen PL
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326
    [No Abstract]   [Full Text] [Related]  

  • 9. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 10. TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health.
    Peck-Radosavljevic M
    Liver Int; 2010 Jan; 30(1):3-4. PubMed ID: 19929902
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in children.
    Kelly D; Sharif K; Brown RM; Morland B
    Clin Liver Dis; 2015 May; 19(2):433-47. PubMed ID: 25921672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of preoperative chemoembolization correlates with outcome after orthotopic liver transplantation in patients with hepatocellular carcinoma].
    Wang Y; Qu M; Shi YF; Liu YJ; Zhang CJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):785-6. PubMed ID: 21059299
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukocytoclastic vasculitis as the form of presentation of hepatocarcinoma].
    Sánchez-Angulo JI; Benítez-Roldán A; Silgado-Rodríguez G; Ruiz-Campos J
    Gastroenterol Hepatol; 1996 May; 19(5):255-8. PubMed ID: 8752569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radical and multimodality therapy for hepatitis C virus-related hepatocellular carcinoma].
    Ikeda K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):821-7. PubMed ID: 7563883
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients.
    Gomatos IP; Alexakis N; Koskinas J; Smparounis SA; Katsaragakis S; Konstadoulakis MM; Zografos GC
    Am Surg; 2013 Jan; 79(1):111-3. PubMed ID: 23317624
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma: latest developments.
    Walzer N; Kulik LM
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
    Reichman TW; Anthony T; Millis JM; Testa G
    Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interventional therapy for hepatocellular carcinoma].
    Wang JH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):721-3. PubMed ID: 16248940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.